Filtered By:
Management: Funding

This page shows you your search results in order of relevance. This is page number 11.

Order by Relevance | Date

Total 11357 results found since Jan 2013.

Redefining Pulmonary Hypertension through Pulmonary Vascular Disease Phenomics: Clinical Centers (CC) (U01)
Funding Opportunity RFA-HL-14-027 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to invite applications to participate in a new NHLBI Pulmonary Vascular Disease Phenomics Program (hereafter referred to as "PVDOMICS"). Teams of investigators will perform comprehensive, deep phenotyping across the current World Health Organization (WHO)-classified pulmonary hypertension (PH) clinical Groups 1 through 5 (http://www.nhlbi.nih.gov/health/health-topics/topics/pah/types.html). This program will consist of up to five clinical centers (CCs) and one data coordinating ce...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 25, 2013 Category: Research Source Type: funding

Physics Week in Review: December 7, 2013
This week kicked off with (another) Giant Leap For SpaceX : as Elon Musk’s company conquered Geostationary Orbit. Meanwhile, NASA funding shuffle alarms planetary scientists since it means that NASA Might Stop Exploring the Planets. The Atlantic ‘s Robinson Meyer explains Why That’s a Terrible Idea. When it comes to planetary science, will NASA soon stand for NADA ? Bill Nye the Science Guy (CEO of the Planetary Society) even produced a videotaped “open letter” to President Barack Obama urging the administration to reverse this potentially catastrophic course.House panel ponders extraterrestri...
Source: Scientific American - Official RSS Feed - December 7, 2013 Category: Science Tags: More Science Source Type: research

EndoShape raises $6.8M for vascular plugs and coils
EndoShape is raising $6.8 million in support of its minimally invasive technologies for occluding blood vessels. EndoShape is in the process of raising $6.8 million in the latest reported funding round for the minimally invasive vessel occlusion devices maker. EndoShape Inc.News Well, Coil Embolization, Endovascular, Funding Roundup, Vascular Closureread more
Source: Mass Device - June 20, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

Neograft raises $11M for vascular sleeve
Massachusetts-based Neograft raises $11 million in support of its Angioshield polymer sleeve for supporting arterial veins. Bay State startup Neograft closed an $11 million equity funding round in support of its vascular sleeve technology. Neograft's Angioshield device "creates a micro-fibrous, polymer sleeve intimately surrounding the outside surface of a harvested vein to mechanically reinforce and protect it from overdilation," according to the company. The technology is not yet approved for clinical use. Neograft Technologies Inc.News Well, Funding Roundup, Vascularread more
Source: Mass Device - July 15, 2014 Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news

Interdisciplinary Research to Understand the Vascular Contributions to Alzheimer's Disease (R01)
Funding Opportunity RFA-AG-15-010 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity announcement is to support interdisciplinary research that will lead to a greater understanding of the mechanisms by which vascular factors contribute to the complex etiology of Alzheimer's disease.
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 25, 2014 Category: Research Source Type: funding

Endometrial signals improve embryo outcome: functional role of vascular endothelial growth factor isoforms on embryo development and implantation in mice
This study was supported by a University of Melbourne Early Career Researcher Grant #601040, the NHMRC (L.A.S., Program grant #494802; Fellowship #1002028; N.J.H., Fellowship # 628927; J.E.; project grant #1047756) and L.A.S., Monash IVF Research and Education Foundation. N.K.B. was supported by an Australian Postgraduate Award. Work at PHI-MIMR Institute was also supported by the Victorian Government's Operational Infrastructure Support Program. There are no conflicts of interest to declare.
Source: Human Reproduction - September 15, 2014 Category: Reproduction Medicine Authors: Binder, N. K., Evans, J., Gardner, D. K., Salamonsen, L. A., Hannan, N. J. Tags: Reproductive biology Source Type: research

First trimester trophoblast and placental bed vascular volume measurements in IVF or IVF/ICSI pregnancies
This study was financially supported by the Erasmus Trustfonds, the Meindert de Hoop foundation and the Fonds NutsOhra. No competing interests are declared.
Source: Human Reproduction - November 11, 2014 Category: Reproduction Medicine Authors: Rifouna, M. S., Reus, A. D., Koning, A. H. J., van der Spek, P. J., Exalto, N., Steegers, E. A. P., Laven, J. S. E. Tags: Early pregnancy Source Type: research

Increased endothelial-derived microparticles in ventilator-induced lung injury
In this study, we characterize EMPs in a murine model of VILI. C57BL/6J mice were subjected to high tidal volume (40mL/kg) mechanical ventilation (VILI). Spontaneously breathing (SB) mice served as control. After 4h, blood/BAL were collected and microparticles (MPs) were isolated by differential centrifugation. MPs were quantified after staining with a marker of endothelial activation, CD62E (Flow cytometry). Plasma MPs were also analyzed by immunoblotting for VE-cadherin. The purity and characteristics (size 0.1 to 1μm) of the isolated MP populations were confirmed by electron microscopy and flow cytometry. VILI-mice e...
Source: European Respiratory Journal - December 23, 2014 Category: Respiratory Medicine Authors: Letsiou, E., Sammani, S., Garcia, J. G., Dudek, S. M. Tags: 4.3 Pulmonary Circulation and Pulmonary Vascular Disease Source Type: research

Vascular Dynamics Inc. Secures $16.85 Million Series B Financing
The Funding Will Be Used to Advance the Company's Program for the Treatment of Resistant Hypertension MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - Vascular Dynamics Inc. (VDI) a medical device company providing minimally invasive solution... Devices, Venture CapitalVascular Dynamics, resistant hypertension, MobiusHD, CALM-FIM
Source: HSMN NewsFeed - January 8, 2015 Category: Pharmaceuticals Source Type: news

Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis
Publication date: Available online 6 February 2015 Source:The Lancet Diabetes & Endocrinology Author(s): Rachel R Huxley , Sanne A E Peters , Gita D Mishra , Mark Woodward Background Studies have suggested sex differences in the mortality rate associated with type 1 diabetes. We did a meta-analysis to provide reliable estimates of any sex differences in the effect of type 1 diabetes on risk of all-cause mortality and cause-specific outcomes. Methods We systematically searched PubMed for studies published between Jan 1, 1966, and Nov 26, 2014. Selected studies reported sex-specific estimates of the standardised m...
Source: The Lancet Diabetes and Endocrinology - February 6, 2015 Category: Endocrinology Source Type: research

Phosphate as a cardiovascular risk factor: effects on vascular and endothelial function
Publication date: 26 February 2015 Source:The Lancet, Volume 385, Supplement 1 Author(s): Kathryn K Stevens , Rajan K Patel , Patrick B Mark , Christian Delles , Alan G Jardine Background Hyperphosphataemia is a risk factor for accelerated cardiovascular disease in chronic kidney disease. The mechanism is poorly understood; it is unclear whether phosphate has direct effects or effects mediated via calcification or FGF23. We investigated direct effects of phosphate on endothelial function using myography to study rat and human blood vessels. In addition we assessed the effects of phosphate loading on endothelial function ...
Source: The Lancet - February 26, 2015 Category: Journals (General) Source Type: research

Corrigendum to Pseudoaneurysm of the dorsalis pedis artery following ankle arthroscopy
The publishers would like to apologize for the following error which appeared in Pseudoaneurysm of the dorsalis pedis artery following ankle arthroscopy by Jung Nam Kwon, Seok Youn Lee and Yu Mi Kim, DOI : 10.1177/1358863X14557153, which was published in Vascular Medicine 2014, Vol. 19(6) 510–511. The year for the funding information was incorrect; it reads 2013 when it should be the following: Funding This paper was supported by Wonkwang University in 2012.
Source: Vascular Medicine - February 26, 2015 Category: Internal Medicine Tags: Corrigendum Source Type: research

Shockwave Medical Announces $40 Million in Funding for Novel Lithoplasty System to Treat Advanced Peripheral, Coronary Vascular and Aortic Valve Disease
Support from Blue-Chip Financial and Strategic Investors Will Advance Product and Clinical Development FREMONT, Calif.--(Healthcare Sales & Marketing Network)--Shockwave Medical, a pioneer in the treatment of peripheral and coronary vascular disease, to... Devices, Interventional, Cardiology, Venture CapitalShockwave Medical, Lithoplasty
Source: HSMN NewsFeed - May 19, 2015 Category: Pharmaceuticals Source Type: news